The acquisition is expected to strengthen Mankind Pharma’s presence in the central nervous system (CNS) segment and complement its existing neuro portfolioThe acquisition is expected to strengthen Mankind Pharma’s presence in the central nervous system (CNS) segment and complement its existing neuro portfolio Latest News [ SOBAN NEWS: International and National ]